Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Unaudited Financial results for ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parmax Pharma Ltd has informed BSE that its Board of Directors will meet on Saturday, February 14, 2026, to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025. The filing is made under Regulation 29 of SEBI Listing Regulations. The company has also confirmed that the trading window for insiders has been closed and will remain so until 48 hours after the results are announced. No actual financial figures or business details have been disclosed in this intimation.
This is a routine regulatory filing and does not, by itself, affect the stock price. Investors should watch the February 14, 2026 results announcement for actual financial performance, which will be the next meaningful catalyst.